| Revenue from sale of goods | 580.75a | 585.84a | 614.2a |
| Interest income | 1.87a | 1.16a | |
| Dividend income | 0.03a | 0.01a | |
| Gains on investments | 0.16a | 7.88a | 2.55a |
| Gains on changes in fair value of investment properties | 0.16a | | |
| Net foreign exchange gains | 0.55a | 1.02a | |
| Other income | 2.82a | 3.77a | |
| Total income | 586.34a | 599.69a | |
| Cost of sale of goods | -495.7a | -529.14a | |
| Distribution costs | -17.69a | -19.14a | |
| Administrative expenses | -32.75a | -32.24a | |
| Gains on changes in fair value of biological assets | -2.36a | -0.72a | |
| Impairment losses | -2.62a | -0.91a | |
| Loss from investment exchange | -0.09a | | |
| Finance cost on lease liabilities | -3.15a | -2.97a | |
| Other finance costs | -21.43a | -22.54a | |
| Total expenses | -571.07a | -606.21a | |
| Share of profit of associates and joint ventures accounted for using equity method | 12.7a | 4.59a | |
| Profit (loss) before income tax expense (income) | 27.97a | -1.93a | |
| Income tax expense (income) | -5.67a | -0.6a | |
| Profit (loss) for the year | 22.3a | -2.53a | |
| Profit (loss) for the year attributable to | — | — | — |
| Equity holders of the company | 19.56a | -5.21a | |
| Non-controlling interests | 2.74a | 2.68a | |
| Others | | | 6.68a |
| Total income | | | 623.43a |
| Cost of sale of goods | | | -532.32a |
| Loss (gains) on changes in fair value of biological assets | | | -1.41a |
| Selling and administrative expenses | | | -55a |
| Finance costs | | | -20.36a |
| Others | | | 0.48a |
| Total expenses | | | -606.75a |
| Share of profits of associates and joint venture | | | 3.75a |
| Profit (loss) before income tax | | | 20.43a |
| Income tax expense | | | -6a |
| Profit (loss) for the year | | | 14.42a |
| Non-controlling interests | | | -0.45a |
| Profit (loss) for the year attributable to equity holders of the company | | | 13.97a |